AAAAAA
Results:
1-13
|
Results: 13
Authors:
SABBATINI P
LIVINGSTON P
LOYD K
AGHAJANIAN C
SPRIGGS D
POYNOR E
CHI D
BROWN C
BARAKAT R
DANISHEFSKY S
HOSKINS W
VENKATRAMAN ES
GOODRICH K
CURTIN J
Citation: P. Sabbatini et al., TARGETED THERAPY IN OVARIAN, FALLOPIAN-TUBE, AND PERITONEAL CANCER - A PHASE-I STUDY OF VACCINATION WITH THE LEWIS Y-KLH CONJUGATE AND QS-21, Annals of oncology, 9, 1998, pp. 317-317
Authors:
AGHAJANIAN C
LEVENBECK C
CHEN Y
PEZZULLI S
BROWN C
CURTIN J
VONROEMELING R
SPRIGGS D
Citation: C. Aghajanian et al., A MULTICENTER PHASE-II STUDY OF TIRAPAZAMINE PLUS CISPLATIN IN PATIENTS WITH METASTATIC OR RECURRENT CERVICAL-CANCER, Annals of oncology, 9, 1998, pp. 666-666
Authors:
AGHAJANIAN C
FENNELLY D
SHAPIRO F
WALTZMAN R
ALMADRONES L
OFLAHERTY C
OCONNER K
VENKATRAMAN E
BARAKAT R
CURTIN J
BROWN C
REICH L
WUEST D
NORTON L
HOSKINS W
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
Authors:
ABURUSTUM NR
AGHAJANIAN C
Citation: Nr. Aburustum et C. Aghajanian, MANAGEMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY, Seminars in oncology, 25(2), 1998, pp. 235-242
Authors:
BARAKAT RR
ALMADRONES L
VENKATRAMAN ES
AGHAJANIAN C
BROWN C
SHAPIRO F
CURTIN JP
SPRIGGS D
Citation: Rr. Barakat et al., A PHASE-II TRIAL OF INTRAPERITONEAL CISPLATIN AND ETOPOSIDE AS CONSOLIDATION THERAPY IN PATIENTS WITH STAGE II-IV EPITHELIAL OVARIAN-CANCERFOLLOWING NEGATIVE SURGICAL ASSESSMENT, Gynecologic oncology, 69(1), 1998, pp. 17-22
Authors:
HUSAIN A
YAN XJ
ROSALES N
AGHAJANIAN C
SCHWARTZ GK
SPRIGGS DR
Citation: A. Husain et al., UCN-01 IN OVARY CANCER-CELLS - EFFECTIVE AS A SINGLE-AGENT AND IN COMBINATION WITH CIS-DIAMMINEDICHLOROPLATINUM(II) INDEPENDENT OF P53 STATUS, Clinical cancer research, 3(11), 1997, pp. 2089-2097
Authors:
FENNELLY D
AGHAJANIAN C
SHAPIRO F
OFLAHERTY C
MCKENZIE M
OCONNOR C
TONG W
NORTON L
SPRIGGS D
Citation: D. Fennelly et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL ADMINISTERED WEEKLY IN PATIENTS WITH RELAPSED OVARIAN-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 187-192
Authors:
ABURUSTUM NR
AGHAJANIAN C
BARAKAT RR
FENNELLY D
SHAPIRO F
SPRIGGS D
Citation: Nr. Aburustum et al., SALVAGE WEEKLY PACLITAXEL IN RECURRENT OVARIAN-CANCER, Seminars in oncology, 24(5), 1997, pp. 62-67
Authors:
FENNELLY DW
AGHAJANIAN C
SHAPIRO F
OFLAHERTY C
OCONNOR K
CURTIN JP
CROWN JP
HOSKINS WJ
SPRIGGS DR
Citation: Dw. Fennelly et al., DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CARBOPLATIN USING PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(1), 1997, pp. 26-30
Authors:
AGHAJANIAN C
BROWN C
OFLAHERTY C
FLEISCHAUER A
CURTIN J
VONROEMELING R
SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-I STUDY OF TIRAPAZAMINE AND CISPLATIN IN PATIENTS WITH RECURRENT CERVICAL-CANCER, Gynecologic oncology, 67(2), 1997, pp. 127-130
Authors:
WANG EH
MA WJ
AGHAJANIAN C
SPRIGGS DR
Citation: Eh. Wang et al., POSTTRANSCRIPTIONAL REGULATION OF PROTEIN EXPRESSION IN HUMAN EPITHELIAL CARCINOMA-CELLS BY ADENINE-URIDINE-RICH ELEMENTS IN THE 3'-UNTRANSLATED REGION OF TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA, Cancer research, 57(23), 1997, pp. 5426-5433
Authors:
GOGAS H
SHAPIRO F
AGHAJANIAN C
FENNELLY D
ALMADRONES L
HOSKINS WJ
SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
Authors:
FENNELLY D
SHAPIRO F
SPRIGGS D
AGHAJANIAN C
FRANCIS P
LEWIS JL
JONES W
CURTIN J
BARAKAT R
HOSKINS W
Citation: D. Fennelly et al., PHASE-I STUDY OF TAXOL ADMINISTERED WEEKLY IN PATIENTS WITH PERSISTENT OVARIAN-CANCER, European journal of cancer, 31A, 1995, pp. 923-923
Risultati:
1-13
|